Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06589973
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-06
Brief Title:
Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
IImpact of Clinical and Biochemical Variables on Mortality and Morbidity of Patients With Alcohol Withdrawal Syndrome Under Treatment According to the CIWA-AR Scale
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to describe the impact measured through the Odds Ratio OR of different variables of clinical and biochemical alterations on the duration of the syndrome alcohol withdrawal patients measured in days of symptoms and stay it could include any patients with a diagnosis of admission of alcohol withdrawal syndrome AWS who have been treated in the department of Internal Medicine for 5 years
The main question it aims to answer is What is the relationship between the different clinical biochemical and hematic factors on the duration of symptoms morbidity and mortality in individuals with alcohol syndrome withdrawal
If the patient has a greater number of risk factors such as advanced age a long and chronic history of alcohol consumption the type of distillate consumed as well as the deterioration of liver function and presence of leukocytosis and neutrophilia then it is postulated that the duration of alcohol withdrawal syndrome will be longer
Clinical records will be used to describe the proportion of complications associated with alcohol withdrawal syndrome including pneumonia bronchial aspiration seizures need for mechanical ventilation digestive tract hemorrhage toxic-alcoholic hepatitis and pancreatitis
The main question it aims to answer is What is the relationship between the different clinical biochemical and hematic factors on the duration of symptoms morbidity and mortality in individuals with alcohol syndrome withdrawal
If the patient has a greater number of risk factors such as advanced age a long and chronic history of alcohol consumption the type of distillate consumed as well as the deterioration of liver function and presence of leukocytosis and neutrophilia then it is postulated that the duration of alcohol withdrawal syndrome will be longer
Clinical records will be used to describe the proportion of complications associated with alcohol withdrawal syndrome including pneumonia bronchial aspiration seizures need for mechanical ventilation digestive tract hemorrhage toxic-alcoholic hepatitis and pancreatitis
Detailed Description:
Clinical records files of patients with a diagnosis of admission of alcohol withdrawal syndrome AAS who have been treated in the Department of Internal Medicine for 5 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None